Christopher B. Ehrlich - 04 Oct 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc.

Role
Director
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Christopher B. Ehrlich
Issuer symbol
N/A
Transactions as of
04 Oct 2022
Net transactions value
+$197
Form type
4
Filing time
06 Oct 2022, 08:30:09 UTC
Previous filing
27 Sep 2022
Next filing
24 Jan 2023
SEC
View on sec.gov

Key filing fact

Christopher B. Ehrlich filed Form 4 for eFFECTOR Therapeutics, Inc. on 06 Oct 2022.

Key facts

  • This page summarizes Christopher B. Ehrlich's Form 4 filing for eFFECTOR Therapeutics, Inc..
  • 1 reported transaction and 0 derivative rows are listed below.
  • Filing timestamp: 06 Oct 2022, 08:30.

Change

  • Previous filing in this sequence was filed on 27 Sep 2022.
  • Current net transaction value: +$197.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

EFTR transaction

Common Stock

Purchase

Transaction value
$197
Shares
+346
Change %
+0.99%
Price
$0.5700
Shares after
35,213
Date
04 Oct 2022
Ownership
Direct
EFTR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
142,168
Date
04 Oct 2022
Ownership
By Locust Walk Partners LLC
Footnotes
F1
EFTR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,034
Date
04 Oct 2022
Ownership
By Locust Walk Partners LLC
Footnotes
F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares held directly by the Sponsor, of which Locust Walk Partners LLC ("LWP") is a member. LWP has allocated these shares to the reporting person.
F2 Represents shares held directly by the Sponsor, of which LWP is a member. LWP has allocated these shares to the reporting person's spouse.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .